FOLLOWUS
Department of Cardiology, Shuguang Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai (201203), China
Dr. WANG Xiao-long, E-mail: wxlqy0214@163.com
纸质出版日期:2022-09,
网络出版日期:2022-07-15,
录用日期:2021-08-09
Scan for full text
Yi-ping LI, Ting-ting QIANG, Ke-yan WANG, 等. 麝香保心丸通过miR-451调控血小板衍生生长因子BB刺激血管平滑肌细胞导致的内膜增生、迁移和凋亡[J]. Chinese Journal of Integrative Medicine, 2022,28(9):785-793.
Yi-ping LI, Ting-ting QIANG, Ke-yan WANG, et al. Shexiang Baoxin Pill Regulates Intimal Hyperplasia, Migration, and Apoptosis after Platelet-Derived Growth Factor-BB-Stimulation of Vascular Smooth Muscle Cells via miR-451[J]. Chinese Journal of Integrative Medicine, 2022,28(9):785-793.
Yi-ping LI, Ting-ting QIANG, Ke-yan WANG, 等. 麝香保心丸通过miR-451调控血小板衍生生长因子BB刺激血管平滑肌细胞导致的内膜增生、迁移和凋亡[J]. Chinese Journal of Integrative Medicine, 2022,28(9):785-793. DOI: 10.1007/s11655-022-2891-6.
Yi-ping LI, Ting-ting QIANG, Ke-yan WANG, et al. Shexiang Baoxin Pill Regulates Intimal Hyperplasia, Migration, and Apoptosis after Platelet-Derived Growth Factor-BB-Stimulation of Vascular Smooth Muscle Cells via miR-451[J]. Chinese Journal of Integrative Medicine, 2022,28(9):785-793. DOI: 10.1007/s11655-022-2891-6.
目的:
2
总结中医药防治新型冠状病毒肺炎 (以下简称“新冠肺炎”) 诊疗方案的用药规律
为临床诊治提供参考.
方法:
2
搜索从2019年12月8日到2020年3月10日的各省市政府网站和官方媒体网站上的中医药防治新冠肺炎诊疗方案. 分防治阶段和地区对诊疗方案的中药组方进行用药频次、中药配伍、聚类以及复杂网络分析等.
结果:
2
在27个中医诊治方案中
治疗处方共有203个
用药频次较高的前4位中药分别为: 甘草、杏仁、麻黄、藿香
核心组合是麻黄和杏仁. 在48个预防处方中
使用频率最高的中药分别为: 黄芪、甘草、防风、金银花等. 核心配伍处方为黄芪、甘草、防风
是玉平风散的主要成分. 中国华东地区的诊疗方案中
防治处方共45个
使用频率最多的中药是甘草、藿香、陈皮和石膏等. 中国华北地区的诊疗方案中
防治处方共50个
使用频率最多的中药是藿香、杏仁、麻黄和茯苓等.
结论:
2
在预防新冠肺炎方面
中医药主要侧重于提高人体免疫力; 治疗上
则重在清肺利湿. 中药处方的应用因地制宜
可能是由于气候和环境的差异
这些结果有助于临床医生快速制定中医药诊疗计划.
Objective:
2
To investigate the regulatory roles of Shexiang Baoxin Pill (SXBXW) in neointimal formation and vascular smooth muscle cells (VSMCs) invasion and apoptosis as well as the potential molecular mechanisms using cultured VSMCs model of vascular injury (platelet-derived growth factor (PDGF)-BB-timulated)
in vitro
.
Methods:
2
VSMCs were randomly assigned to 5 groups: blank
PDGF-BB (20 ng/mL+ 0.1% DMSO)
SXBXW-L (PDGF-BB 20 ng/mL + SXBXW low dose 0.625 g/L)
SXBXW-M (PDGF-BB 20 ng/mL + SXBXW medium dose 1.25 g/L) and SXBXW-H (PDGF-BB 20 ng/mL+ SXBXW high dose 2.5 g/L) group. Cell proliferation was assessed using cell counting kit-8 (CCK-8) assay and bromodeoxyuridine (BrdU) incorporation assay
the migration effects were detected by Transwell assay
cell apoptosis rate was measured by the Annexin V/propidium iodide (PI) apoptosis kit. The markers of contractile phenotype of VSMCs were detected with immunofluorescent staining. To validate the effects of miR-451 in regulating proliferation
migration and apoptosis treated with SXBXW
miR-451 overexpression experiments were performed
the VSMCs were exposed to PDGF-BB 20 ng/mL + 0.1% DMSO and later divided into 4 groups: mimic-NC (multiplicity of infection
MOI=50)
SXBXW (1.25 g/L) + mimic-NC
mimic-miR451 (MOI=50)
and SXBXW (1.25 g/L) + mimic-miR451
and alterations of proteins related to the miR-451 pathway were analyzed using Western blot.
Results:
2
PDGF-BB induced VSMCs injury causes acceleration of proliferation and migration. SXBXW inhibited phenotypic switching
proliferation and migration and promoted cell apoptosis in PDGF-BB-induced VSMCs. In addition
miR-451 was shown to be down-regulated in the VSMCs following PDGF-BB stimulation. SXBXW treatment enhanced the expression of miR-451 in PDGF-BB-induced VSMCs (
P
<
0.05). Compared with SXBXW + mimic-NC and mimic-miR451 groups
the expression of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (Ywhaz) and p53 was further reduced in SXBXW + mimic-miR451 group
while activating transcription factor 2 (ATF2) was increased in VSMCs (
P
<
0.05).
Conclusion:
2
SXBXW regulated proliferation
migration and apoptosis via activation of miR-451 through ATF2
p53 and Ywhaz in PDGF-BB-stimulated VSMCs.
麝香保心丸miR-451血小板源性生长因子BB刺激的血管平滑肌细胞增殖凋亡
Shexiang Baoxin PillsmiR-451platelet-derived growth factor-BB-stimulated vascular smooth muscle cells proliferationapoptosis
Weber C, Badimon L, Mach F, van der Vorst EPC.Therapeutic strategies for atherosclerosis and atherothrombosis: Past, present and future. Thromb Haemostasis 2017;117:1258-1264.
Gomez D, Owens GK. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 2012;95:156-164.
Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res 2016;118:692-702.
Li L, Li Y, Tang C. The role of microRNAs in the involvement of vascular smooth muscle cells in the development of atherosclerosis. Cell Biol Int 2019;4:1102-1112.
Hajibabaie F, Kouhpayeh S, Mirian M, Rahimmanesh I,Boshtam M, Sadeghian L, et al. MicroRNAs as the actors in the atherosclerosis scenario. J Physiol Biochem 2020;76:1-12.
Lu L, Sun XD, Chen C, Qin YT, Guo XM. Shexiang Baoxin Pill, derived from the traditional Chinese medicine, provides protective roles against cardiovascular diseases. Front Pharmacol 2018;9:1161.
Gravina HD, Antonelli L, Gazzinelli RT, Ropert C.Differential use of TLR2 and TLR9 in the regulation of immune responses during the infection with Trypanosoma cruzi. PLoS One 2013;5:e63100.
Zhang W, Liu D, Han X, Ren J, Zhou P, Ding P.MicroRNA-451 inhibits vascular smooth muscle cell migration and intimal hyperplasia after vascular injury via Ywhaz/p38 MAPK pathway. Exp Cell Res 2019;379:214-224.
Lian C, Wang Z, Qiu J, Jiang B, Lv J, He R, et al. TIM-3 inhibits PDGF-BB-induced atherogenic responses in human artery vascular smooth muscle cells. Mol Med Rep 2020;22:886-894.
Shi J, Yang Y, Cheng A, Xu G, He F. Metabolism of vascular smooth muscle cells in vascular diseases. Am J Physiol Heart Circ Physiol 2020;319:H613-H631.
Li R, Jiang Q, Zheng Y. Circ_0002984 induces proliferation, migration and inflammation response of VSMCs induced by ox-LDL through miR-326-3p/VAMP3 axis in atherosclerosis. J Cell Mol Med 2021;10.
Dobnikar L, Taylor AL, Chappell J, Oldach P, Harman JL,Oerton E, et al. Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vessels. Nat Commun 2018;9:4567.
Aravani D, Foote K, Figg N, Finigan A, Uryga A, Clarke M, et al. Cytokine regulation of apoptosis-induced apoptosis and apoptosis-induced cell proliferation in vascular smooth muscle cells. Apoptosis 2020;25:648-662.
Liu Y, Li H, Li LH, Tang JB, Sheng YL. Mir-451 inhibits proliferation and migration of non-small cell lung cancer cells via targeting LKB1/AMPK. Eur Rev Med Pharmacol Sci 2019;23:274-280.
Nan Y, Guo H, Guo L, Wang L, Ren B, Yu K, et al. MiRNA-451 inhibits glioma cell proliferation and invasion through the mTOR/HIF-1alpha/VEGF signaling pathway by targeting CAB39. Hum Gene Ther Clin Dev 2018;29:156-166.
Liu W, Liu SY, He YB, Huang RL, Deng SY, Ni GX, et al. MiR-451 suppresses proliferation, migration and promotes apoptosis of the human osteosarcoma by targeting macrophage migration inhibitory factor. Biomed Pharmacother 2017;87:621-627.
Qiu M, Yang Z, Guo XH, Song YT, An M, Zhao GJ, et al.Trichosanthin attenuates vascular injury-induced neointimal hyperplasia following balloon catheter injury in rats. J Toxicol Environ Health A 2017;88:1212-1221.
Li X, Du JR, Yu Y, Bai B, Zheng XY. Tanshinone ⅡA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signaling pathway. J Ethnopharmacol 2010;129:273-279.
Liu Y, Jia L, Min D, Xu Y, Zhu J, Sun Z. Baicalin inhibits proliferation and promotes apoptosis of vascular smooth muscle cells by regulating the MEG3/p53 pathway following treatment with ox-LDL. Int J Mol Med 2019;43:901-913.
Zhang MF, Fei ZW, Huang L. Micro-RNA-451 reduces proliferation of B-CPAP human papillary thyroid cancer cells by downregulating expression of activating transcription factor 2. Med Sci Monit 2021;27:e929774.
0
浏览量
7
Downloads
0
CSCD
关联资源
相关文章
相关作者
相关机构